INKON Life Achieves 1.56 Million Total Patient Visits, Pioneering a Quality-Driven Path for Private Healthcare with Full-Cycle Oncology Ecosystem

On the evening of March 29, INKON Life released its 2022 annual report.

Data shows that against the backdrop of a severe domestic and international economic situation in 2022, INKON Life achieved a total revenue of RMB 1.156 billion, representing a year-on-year increase of 6.09%. Of this, revenue from the medical services segment amounted to RMB 997 million, while revenue from the medical devices segment reached RMB 160 million. These steadily growing financial figures indicate that INKON Life has found its own rhythm of development.

Notably, INKON Life has continued to strengthen its medical services segment. The company provides “specialized-focused, comprehensive-strong” medical services characterized by whole-course, full-cycle comprehensive treatment for tumors. During the reporting period,The six hospitals under operation and management cover a total area of over 320,000 square meters, with a bed capacity of 3,258. The total number of patient visits reached 1.56 million, representing a year-on-year increase of 155%, while the total outpatient volume amounted to approximately 1.486 million visits.

INKON Life is also continuously increasing its investment in digital healthcare to strengthen its medical services. During the reporting period, INKON Life not only completed the construction of “Experience Cloud,” the overarching online medical platform of INKON Life Group, thereby establishing ecosystem service capabilities for its digital healthcare platform, but also enhanced resource sharing among digital systems, medical equipment, and medical experts.

A review of INKON Life’s 2022 annual report by VCBeat reveals that the company is centering its strategy on discipline development and focusing on oncology specialization. Leveraging the policy-driven momentum encouraging private healthcare provision and the integrated development of the entire oncology industry chain, INKON Life is striving to build an ecological network covering the full spectrum of “prevention, diagnosis, treatment, and rehabilitation” in oncology, ultimately facilitating the high-quality development of private healthcare institutions.

Data shows that hospitals under INKON Life Technology Co., Ltd. have a total bed capacity of 3,258, with 1.56 million total patient visits, representing a year-on-year increase of 155%. The combined outpatient volume reached 1.486 million visits. Revenue from oncology services accounted for 27% of the hospital operations’ income, while the competitiveness of major disciplines such as thoracic surgery and cardiovascular medicine is gradually becoming evident.

On one hand, INKON Life Technology Co., Ltd. expands its regional service capacity and influence through mergers and acquisitions, trusteeships, and other means.During the reporting period, the six hospitals operated and managed by INKON Life actively met regional healthcare service demands and received substantial positive feedback. Among them, Sichuan Friendship Hospital (Grade 3A), Suzhou Guangci Tumor Hospital (Grade 2A), and Shanghai Yongci Rehabilitation Hospital were honored as 5-Star 3A Hospitals by the Chinese Non-Public Medical Institutions Association. Additionally, Yuncheng First Hospital was listed among the Top 100 Private Hospitals in China by Ailibei.

In 2022, the “Chengdu Jinjiang District Cancer Prevention and Control Center,” spearheaded by the Health Commission of Jinjiang District, Chengdu, was officially established and accredited at Sichuan Friendship Hospital. This signifies that the hospital will assume the responsibility of exploring a cancer prevention and control service model tailored to the characteristics of Jinjiang District, elevating the district’s cancer prevention and control capabilities to a new level and advancing scientific research achievements to greater heights. Meanwhile, the competitiveness of other specialized disciplines under INKON Life has gradually improved, with 17 key specialized departments and projects at or above the municipal level being established, designated by health commissions or non-public medical associations.

On the other hand, INKON Life is also strengthening its competitiveness in key disciplines, regional ecosystem networks, and digital health management capabilities, thereby improving the quality of development and connotative construction of its hospitals.

INKON Life, adhering to its positioning of “specialized excellence with comprehensive strength,” has proposed a strategy to build “major disciplinary centers.” This initiative aims to promote the flow of high-quality medical resources through platform-sharing mechanisms and enhance the core clinical specialty service capabilities of its hospitals. During the reporting period, INKON Life established major disciplinary centers for Imaging and Cardiology. Notably, the Cardiology Major Disciplinary Center has demonstrated significant cross-regional empowerment effects, facilitating an increase of 257 interventional cardiology procedures at Sichuan Friendship Hospital. Meanwhile,INKON Life Expands the Construction of Major Disciplinary Centers from Cardiology and Imaging to Thoracic Oncology, continuously building service capabilities for specialized diseases under our advantageous specialties.

INKON Life is also discipline-group-oriented, having continuously introduced 39 new technologies to enhance the quality of hospital disciplines.INKON Life’s affiliated hospitals saw the proportion of Level 3 and Level 4 surgeries reach 72%, a year-on-year increase of 20%.. Taking Suzhou Guangci Tumor Hospital as an example, the hospital performed nearly 5,000 surgeries in 2022, a year-on-year increase of 19%, with Level III and IV surgeries accounting for 71% of the total, a year-on-year increase of 44%.

Centered on disciplinary development, INKON Life has established standardized clinical pathways for its advantageous disease categories.Taking Yuncheng First Hospital as an example, the clinical pathway enrollment rate at this hospital is 59.6%, exceeding the national standard of 50%, with a completion rate of 69.5%. Additionally, the hospital has established a multidisciplinary treatment pathway for cervical cancer, completing both the development of documentation and implementation across relevant departments.

Talent is the engine driving the development of private healthcare. In terms of talent development, INKON Life has established a pyramid-shaped tiered structure for its medical and health workforce.AtWithin the INKON Life ecosystem, there are over 3,100 medical professionals, with those holding intermediate and senior professional titles accounting for 47%.. In addition, INKON Life is actively engaging in industry-academia-research collaborations with institutions such as Soochow University Medical College, Chengdu Medical College, Chengdu University of Traditional Chinese Medicine, and Shanxi Medical University to support disciplinary development.

If the “University Discipline Center” represents INKON Life’s endogenous development path, then the Regional Medical Centers constitute its exogenous manifestation. Specifically, INKON Life leverages its existing network of Regional Medical Centers to build a prevention-oriented health system and facilitate the downward distribution of high-quality medical resources in alignment with national policy directives.

INKON Life provides pre- and post-hospital health solutions centered on “Prevention–Recovery” for users., forming a home-based medical service network. By building specialized ecosystems in areas such as oncology and chronic disease management, it provides value-added services to patients, enhances user stickiness and user value, and ultimately achieves integration with the Haier Smart Home ecosystem.

Leveraging its internet hospital platform, INKON Life integrates pre-consultation, in-consultation, and post-consultation services, achieving seamless connectivity between its online platform and offline physical hospitals. This has enhanced the continuity, diversity, efficiency, and patient stickiness of medical services. During the reporting period,The internet hospital added 548,000 new users throughout the year, a year-on-year increase of 308%; online service orders reached 1.04 million, a year-on-year increase of 765%; and the total value of online orders amounted to RMB 20.34 million, a year-on-year increase of 212%.. Taking Sichuan Friendship Hospital as an example, 100% of its existing patients were onboarded to the platform, with 370,000 new users registered, an online appointment registration rate of 34%, and 930,000 online service encounters delivered.

During the COVID-19 pandemic prevention and control period,Hospitals Under INKON Life Strengthen Public Service Functions Within Their Jurisdictions, strengthen collaboration with communities and enhance regional reputation by providing accessible medical services. For instance, a regional medical consortium led by Sichuan Friendship Hospital, comprising 49 member institutions, leverages its internet hospital to offer online consultations, expert advisory services, and home delivery of medications to communities, enabling patients to remain connected to care even after discharge and creating a closed-loop “hospital-community-home” interconnected ecosystem. By enhancing community service capabilities, Sichuan Friendship Hospital saw a 14% year-on-year increase in outpatient visits and hospital admissions in 2022.

INKON Life has also made significant investments in digitalization, throughBuild an integrated digital operations system, digital experience platform, and digital therapeutics applications spanning operations, supply chain, and post-care management, providing digital-intelligence integration support for the development of hospitals and the ecosystem. Taking digital therapeutics as an example, Shanghai Yongci Rehabilitation Hospital, under INKON Life Technology Co., Ltd., has established a Rehabilitation Robotics Hub, achieving a 20-fold increase in medical staff efficiency through rehabilitation digital therapeutics; it is also collaborating with partners to advance the development of AI diagnostic software for comprehensive pituitary diagnosis, among other initiatives.

By providing full-cycle oncology services spanning prevention, diagnosis, treatment, and rehabilitation across in-hospital, community, and home settings, INKON Life delivers more convenient and comprehensive medical care to cancer patients. This approach is poised to genuinely enhance patients’ quality of life, fulfilling its mission to “bring lifelong health and well-being to all.”

It is worth noting that, according to the latest financial report released by INKON Life Technology Co., Ltd. (“INKON Life”), medical devices remain a vital component of its ecosystem and serve as a key pillar in its strategy to build a full-chain ecosystem for tumor prevention, diagnosis, treatment, and rehabilitation. For instance, during the reporting period, INKON Life acquired Hebei Ailikesen and Shenzhen Shengnuo Medical to strengthen its R&D and channel capabilities, enrich its product portfolio, and established the INKON Life Medical Device Digital Intelligence Industrial Park, creating an organizational and ecological platform with industrial cluster advantages and deep synergistic capabilities.

It is worth noting that,INKON Life’s medical device business segment generated revenue of RMB 160 million, representing a year-on-year increase of 157.96%. This growth was driven by the launch of the new shortwave therapy device for external use and the contribution from multi-category products offered by Shengnuo Medical, which was acquired by the company.

Founded in 1998, INKON Life has, after more than two decades of transformation and development, become a leading comprehensive provider of tumor radiotherapy equipment and operator of oncology medical services in China.

Focusing on the oncology sector is the most distinctive feature of INKON Life’s business. This strategy represents a prudent decision made by INKON Life in response to policy directives and market demand.

The reality is that, on one hand, there is a cancer patient population in the millions, and on the other, the “Healthy China 2030” Planning Outline sets forth the requirement to “increase the overall five-year cancer survival rate by 15% by 2030.” With limited capacity expansion and fully occupied beds in public hospitals, private hospitals will serve as a vital supplement.

The ensuing question is that, although private healthcare institutions have surpassed public hospitals in both scale and growth rate, their capacity to fulfill the national“Key Component, Vital Force”social expectations are not yet aligned. Therefore, private healthcare providers need to identify a breakthrough point to achieve an upgrade from quantitative growth to qualitative transformation, thereby supplying more medical resources to society as a whole.

A series of national and local policies have long provided reference answers:WantFacilitating the Complementary Development of Private and Public Hospitals by Pursuing SpecializationThis trend aligns perfectly with INKON Life’s early strategic focus on the oncology specialty sector.

As China enters a stage of high-quality social development, private healthcare, as an important component of the medical industry, must advance its own high-quality development—an inevitable requirement of the times.As a well-known brand in the field of private healthcare, INKON Life is also building an ecosystem for its intelligent platform covering the entire chain of tumor prevention, diagnosis, treatment, and rehabilitation.

Reviewing INKON Life’s full-industry-chain ecosystem for oncology, the company has progressively established direct connections with hospitals, patients, medical device manufacturers, and health-tech enterprises, serving as both the architect and connector of this ecosystem, as well as an indispensable participant.

In the vast oncology market, competitive advantages hinge on ecosystem operational capabilities, the completeness of medical devices and services, and the refinement of each stage in the “prevention, diagnosis, treatment, and rehabilitation” continuum. Financial reports indicate that INKON Life is well-prepared, with significant enhancements in its medical service delivery, digital technology capabilities, and ability to extend medical resources to grassroots levels. Will INKON Life continue to inject new momentum into the healthcare industry in 2023? It remains to be seen.